Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, Feb. 16 '25)

Image
By G.M.

 


    Am J Obstet Gynecol

  1. DOMGUE JF, Chandra M, Yu R, Shete S, et al
    Adherence to cervical cancer screening among sexual and racial/ethnic minorities during the covid-19 pandemic in the United States.
    Am J Obstet Gynecol. 2025 Feb 7:S0002-9378(25)00088.
    PubMed        


    Antiviral Res

  2. SCHREIBER A, Ludwig S
    Host-targeted antivirals against SARS-CoV-2 in clinical development - Prospect or disappointment?
    Antiviral Res. 2025;235:106101.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  3. TORRES C, Lyden E, Gillett G, Rupp ME, et al
    Dropping the urine culture: sustained CAUTI reduction using a UTI order panel.
    Infect Control Hosp Epidemiol. 2025 Feb 13:1-7. doi: 10.1017/ice.2025.
    PubMed         Abstract available

  4. SAPIANO MRP, Dudeck MA, Patel PR, Binder AM, et al
    Patient safety as a measure of resilience in US hospitals: central line-associated bloodstream infections, July 2020 through June 2021.
    Infect Control Hosp Epidemiol. 2025 Feb 14:1-7. doi: 10.1017/ice.2024.
    PubMed         Abstract available


    Int J Infect Dis

  5. ZAMPIERI F, Michieletto F, Zanatta A
    Rise and fall of the Myth of the Good Pathogen in Evolutionary Biology and Medicine.
    Int J Infect Dis. 2025 Feb 5:107836. doi: 10.1016/j.ijid.2025.107836.
    PubMed         Abstract available

  6. LESLIE A, Chapman SA, Tessier KM, Tignanelli C, et al
    Beyond the Guidelines: Original Research on Real-World Outcomes of Anticoagulation and Corticosteroid in COVID-19.
    Int J Infect Dis. 2025 Feb 8:107834. doi: 10.1016/j.ijid.2025.107834.
    PubMed         Abstract available

  7. SHINZATO A, Hibiya K, Nishiyama N, Ikemiyagi N, et al
    Unseasonal respiratory syncytial virus epidemics during the COVID-19 pandemic: relationship between climatic factors and epidemic strain switching.
    Int J Infect Dis. 2025 Feb 8:107833. doi: 10.1016/j.ijid.2025.107833.
    PubMed         Abstract available


    Intensive Care Med

  8. ROWLAND A, Boulanger C, Dalton L
    Supporting the bereaved child in the adult ICU: a narrative review.
    Intensive Care Med. 2025 Feb 12. doi: 10.1007/s00134-025-07813.
    PubMed         Abstract available


    J Infect

  9. NOBLE C, McDonald E, Nicholson S, Biering-Sorensen S, et al
    Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response.
    J Infect. 2025 Feb 6:106436. doi: 10.1016/j.jinf.2025.106436.
    PubMed         Abstract available


    J Med Virol

  10. HIKMAT H, Le Targa L, Boschi C, Py J, et al
    Five-Year (2017-2022) Evolutionary Dynamics of Human Coronavirus HKU1 in Southern France With Emergence of Viruses Harboring Spike H512R Substitution.
    J Med Virol. 2025;97:e70217.
    PubMed         Abstract available

  11. MAO T, Zhang P, Jiang S, Li D, et al
    Oral Ad5 Vector-Based SARS-CoV-2 Vaccine Effectively Induces Mucosal and Systemic Immune Responses in BALB/c Mice.
    J Med Virol. 2025;97:e70236.
    PubMed         Abstract available

  12. KALO E, Basyouni Z, Katz GM, Karkvandi V, et al
    Real-World Effectiveness of Sotrovimab in Patients Infected With SARS-CoV-2 Omicron Subvariant BA.2 in Western Sydney, Australia.
    J Med Virol. 2025;97:e70235.
    PubMed         Abstract available

  13. BERGNA A, Lai A, Sagradi F, Menzo S, et al
    Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era.
    J Med Virol. 2025;97:e70215.
    PubMed         Abstract available

  14. ZHAO M, Lei L, Jiang Y, Tian Y, et al
    Unveiling the Threat of Disease X: Preparing for the Next Global Pandemic.
    J Med Virol. 2025;97:e70227.
    PubMed         Abstract available

  15. YE J, Zhang R, Zhou J, Xu T, et al
    Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS-CoV-2 via Combined Experiments.
    J Med Virol. 2025;97:e70229.
    PubMed         Abstract available

  16. MUKHOPADHYAY R, Lambisia AW, Hoang JP, Ravenhill BJ, et al
    Adenovirus-Specific T Cells in Adults Are Frequent, Cross-Reactive to Common Childhood Adenovirus Infections and Boosted by Adenovirus-Vectored Vaccines.
    J Med Virol. 2025;97:e70222.
    PubMed         Abstract available

  17. TORRES AR, Gaio V, Melo A, Lanca M, et al
    RSV-Bacterial Co-Infection Is Associated With Increased Illness Severity in Hospitalized Children - Results From a Prospective Sentinel Surveillance Study.
    J Med Virol. 2025;97:e70209.
    PubMed         Abstract available

  18. WANG S, Sun J, Hu Y, Zhang W, et al
    Clinical and Multiorgan Proteomics Characteristics of the Diverse Fatal Phase in Super Elderly Patients With SARS-CoV-2 Infection: A Descriptive Study.
    J Med Virol. 2025;97:e70207.
    PubMed         Abstract available


    J Virol

  19. CAO X, Liu Y, Tong W, Qin W, et al
    POLM inhibits porcine epidemic diarrhea virus replication by degrading multiple viral structural proteins.
    J Virol. 2025 Feb 10:e0227824. doi: 10.1128/jvi.02278.
    PubMed         Abstract available

  20. FURUSAWA Y, Kiso M, Uraki R, Sakai-Tagawa Y, et al
    Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures.
    J Virol. 2025 Feb 12:e0221724. doi: 10.1128/jvi.02217.
    PubMed         Abstract available

  21. ZHU H, Lou J, Yang Z, Bai J, et al
    STT3B promotes porcine epidemic diarrhea virus replication by regulating N-glycosylation of PEDV S protein.
    J Virol. 2025 Feb 13:e0001825. doi: 10.1128/jvi.00018.
    PubMed         Abstract available

  22. MA R, Zhang X, Li R, Dong X, et al
    PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.
    J Virol. 2025 Feb 13:e0208524. doi: 10.1128/jvi.02085.
    PubMed         Abstract available


    Lancet

  23. WONG WC, Lin V, Fang X, Kidd M, et al
    The Lancet Commission on Transforming Primary Health Care in the Post-COVID-19 Era.
    Lancet. 2025 Feb 10:S0140-6736(25)00198-9. doi: 10.1016/S0140-6736(25)00198.
    PubMed        


    Lancet Infect Dis

  24. PROAL AD, Aleman S, Bomsel M, Brodin P, et al
    Targeting the SARS-CoV-2 reservoir in long COVID.
    Lancet Infect Dis. 2025 Feb 10:S1473-3099(24)00769.
    PubMed         Abstract available

  25. CHEN L, Kaku Y, Okumura K, Uriu K, et al
    Virological characteristics of the SARS-CoV-2 LP.8.1 variant.
    Lancet Infect Dis. 2025 Feb 10:S1473-3099(25)00079.
    PubMed        


    N Engl J Med

  26. FURIE RA, Rovin BH, Garg JP, Santiago MB, et al
    Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.
    N Engl J Med. 2025 Feb 7. doi: 10.1056/NEJMoa2410965.
    PubMed         Abstract available

  27. WANG JJ, Warkentin TE, Schonborn L, Wheeler MB, et al
    VITT-like Monoclonal Gammopathy of Thrombotic Significance.
    N Engl J Med. 2025 Feb 12. doi: 10.1056/NEJMoa2415930.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »